Craig A Clifford, DVM, MS, DACVIM (Oncology) talks about the most common bladder tumor in dogs, misdiagnosis, and the Cadet ...

Updated results from the CheckMate 274 trial support the use of adjuvant nivolumab as standard care for high-risk muscle-invasive urothelial carcinoma, according to researchers.

While several molecular markers that are used to evaluate the development and prognosis of bladder cancer have been studied, the limited value of these established markers has created the need for ...

Julia's Stepping Stones OTT release date is here. Julia's Stepping Stones, the last movie directed by Academy Award winner ...

The trial showed event-free survival and overall survival benefit leading to ... We focused mainly in the frontline setting ...

The majority of the time, this cancer forms on the inner lining of the bladder [urothelial cells ... high-risk NMIBC patients ...

(UroToday.com) The 2024 SUO annual meeting included a urothelial carcinoma session, featuring a presentation ... time and 12 months Duration of response High-grade recurrence-free survival Progression ...

Bicycle Therapeutics presented data on zelenectide pevedotin, highlighting enhanced efficacy in cancer patients with NECTIN4 ...

First-of-its-kind research looking at survival rates for patients with incurable larynx cancer has been published.

Neoadjuvant therapy for high-risk renal cell carcinoma (RCC) may offer a survival advantage over adjuvant therapy, according to data presented at the 2024 annual meeting of the Society of Urologic ...

Tyra Biosciences' shares have dropped sharply after interim data from TYRA-300 showed a superior but not exceptional adverse ...